Clinical Trial Update: Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401) [Phase 4]

View source ↗

Summary

A Phase 4 follow-up study assessing seropersistence after a first booster and response to a second booster for tick-borne encephalitis in participants aged chil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tick-borne Encephalitis

Drugs mentioned

• Pfizer Tick-Borne Encephalitis vaccine

Snippet

Sponsor: Pfizer | Conditions: Encephalitis, Tick-Borne | Phase 4 | Status: COMPLETED | Results posted: 2018-12-17